Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHair loss is a recognised side effect of Mounjaro (tirzepatide), and it tends to appear a few weeks into treatment when weight loss is happening quickly. The most common cause is telogen effluvium — a temporary, stress-triggered shed — rather than anything the medicine is doing to your hair follicles directly. Most side effects reported with Mounjaro are gastrointestinal, but hair thinning shows up consistently enough in clinical experience that it has its own pattern and a clear explanation. Mounjaro is a prescription-only medicine; a prescriber reviews your full medical picture before any treatment is approved, and that conversation is the right place to raise concerns like this.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
This is a question our prescribers hear most weeks, and the honest answer is that it is usually both and neither at the same time. Tirzepatide itself is not thought to damage hair follicles. What it does is help the body lose weight quickly, and rapid weight loss is a well-established trigger for telogen effluvium, a condition where a larger proportion of hairs enter the resting phase simultaneously and then shed together weeks later. The calorie deficit that makes treatment effective can temporarily reduce the nutrients available to follicles, particularly protein, iron and certain B vitamins. Add in the mild physiological stress of a changing metabolism and you have the classic setup for a temporary shed.
This does not mean the medicine is harming you. The NHS tirzepatide medicines page lists hair loss among the less common side effects reported in clinical trials, but the data from those trials and post-marketing experience point clearly to the caloric and metabolic change as the driver, not the molecule itself. That distinction matters because it changes what you do about it, and our dedicated page on Mounjaro and hair loss explains it in full alongside the evidence. You can read a broader breakdown of Mounjaro's side-effect profile if you want to put hair changes in context with the other effects people report.
Telogen effluvium has a characteristic delay. The hair you notice falling out in the shower was pushed into the resting phase weeks earlier, so the shed tends to peak roughly 6–12 weeks after the trigger, whether that is the start of treatment, a fast weight-loss phase, or a dose increase. People are sometimes alarmed precisely because the timing feels disconnected from anything obvious.
For most people the worst of it is over within three to six months. Follicles are not destroyed; they cycle back into the growth phase once the body stabilises, nutrition improves, and the rate of weight loss slows from rapid to steady. A smaller group continues to notice thinning for longer, particularly if intake of protein or key micronutrients stays low throughout treatment. A useful starting point for checking whether your diet is supporting recovery is the NHS healthy weight guidance on nutrition, which covers the fundamentals of eating well alongside any weight-management programme.
If shedding is heavy, prolonged beyond six months, or accompanied by scalp changes, other symptoms, or a personal or family history of androgenetic alopecia, it is worth mentioning to your prescriber or GP. Other causes (thyroid changes, iron deficiency anaemia, or pattern hair loss) can run alongside or independently of telogen effluvium and need separate investigation. You can also explore whether hair loss is a formal side effect of Mounjaro and what the clinical evidence says in more detail.
There is no single remedy that stops telogen effluvium outright, but several things genuinely help. Protein is the priority: aim to keep intake adequate throughout treatment, since appetite suppression makes it easy to under-eat protein without realising. Your prescriber or a dietitian can give you a personal target, but the general principle is that follicles need amino acids to rebuild. Iron is the second most common deficiency to check, a blood test will tell you where you stand. Biotin supplements are widely marketed for hair loss; evidence for them is weak unless you have a confirmed deficiency, though they carry low risk.
Being gentle with your hair helps reduce mechanical loss: wide-tooth combs, loose styles, and avoiding aggressive heat make a measurable difference when the shed is already increased. None of these steps require pausing or stopping treatment. Practical guidance on reducing hair loss during Mounjaro treatment covers these strategies in more depth, including the nutritional targets that support follicle recovery. It is also worth reading what people typically experience over the full arc of treatment on our hair loss after Mounjaro page, which covers what happens once weight loss plateaus.
Hair thinning alone is rarely a reason to stop tirzepatide, but there are signs that need prompt medical attention. Contact your GP or call NHS 111 if you notice severe or persistent stomach pain that extends to your back, with or without vomiting, this can be a sign of pancreatitis, which the MHRA highlighted in a Drug Safety Update for GLP-1 medicines in January 2026. Equally, signs of a serious allergic reaction (swelling, difficulty breathing, rapid heart rate), severe dehydration from persistent vomiting or diarrhoea, or sudden changes in vision all warrant urgent attention rather than waiting for a routine review.
For hair-specific concerns that are worsening despite good nutrition and time, ask your prescriber for a referral to a dermatologist or trichologist. They can distinguish telogen effluvium from other forms of hair loss that may need different treatment. If you experience any suspected side effect, you can report it directly to the MHRA using the Yellow Card scheme, this helps build the post-marketing safety picture for all patients on newer medicines. Our prescribers discuss side-effect patterns like this as part of every consultation; if you have questions about whether Mounjaro is suitable for you, a free consultation with the nume clinical team is the right place to start.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.